Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Joseph Schwartz's Stock Ratings
Leerink Partners Analyst
Joseph Schwartz is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
21.3%
Smart Score
Overall Average Return Percentile
78th
Number of Ratings
202
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/03/2025 | APLT | Buy Now | Applied Therapeutics | $0.11 | 787.31% | $2 → $1 | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/03/2025 | SPRB | Buy Now | Spruce Biosciences | $83.41 | 91.82% | → $160 | Upgrade | Market Perform → Outperform | Get Alert | |
| 12/03/2025 | DSGN | Buy Now | Design Therapeutics | $9.12 | 53.51% | $7 → $14 | Upgrade | Market Perform → Outperform | Get Alert | |
| 12/03/2025 | IFRX | Buy Now | InflaRx | $0.98 | 104.06% | $5 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/03/2025 | BMRN | Buy Now | BioMarin Pharmaceutical | $52.23 | 14.88% | $82 → $60 | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/03/2025 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.53 | 3.03% | $15 → $16 | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/10/2025 | QURE | Buy Now | uniQure | $22.63 | 165.13% | $68 → $60 | Maintains | Outperform | Get Alert | |
| 11/10/2025 | MNPR | Buy Now | Monopar Therapeutics | $75.12 | 53.09% | → $115 | Initiates | → Outperform | Get Alert | |
| 10/27/2025 | RNA | Buy Now | Avidity Biosciences | $71.86 | 0.19% | $65 → $72 | Downgrade | Outperform → Market Perform | Get Alert | |
| 10/21/2025 | SPRB | Buy Now | Spruce Biosciences | $83.41 | 91.82% | $10 → $160 | Maintains | Market Perform | Get Alert | |
| 09/29/2025 | CRNX | Buy Now | Crinetics Pharmaceuticals | $49.32 | 78.43% | $80 → $88 | Maintains | Outperform | Get Alert | |
| 09/24/2025 | QURE | Buy Now | uniQure | $22.63 | 200.49% | $48 → $68 | Maintains | Outperform | Get Alert | |
| 09/09/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | -30.29% | $12 → $15 | Maintains | Market Perform | Get Alert | |
| 07/07/2025 | KALV | Buy Now | KalVista Pharma | $16.90 | 18.34% | $18 → $20 | Maintains | Outperform | Get Alert | |
| 06/10/2025 | INSM | Buy Now | Insmed | $196.92 | -41.6% | $100 → $115 | Maintains | Outperform | Get Alert | |
| 05/23/2025 | FULC | Buy Now | Fulcrum Therapeutics | $12.61 | -4.86% | $4 → $12 | Upgrade | Market Perform → Outperform | Get Alert | |
| 04/30/2025 | RGLS | Buy Now | Regulus Therapeutics | — | — | → $7 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/25/2025 | MAZE | Buy Now | Maze Therapeutics | $39.50 | -29.11% | → $28 | Initiates | → Outperform | Get Alert | |
| 10/11/2024 | TVTX | Buy Now | Travere Therapeutics | $35.00 | 14.29% | $20 → $40 | Maintains | Outperform | Get Alert | |
| 10/08/2024 | TVTX | Buy Now | Travere Therapeutics | $35.00 | -42.86% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/19/2024 | APLT | Buy Now | Applied Therapeutics | $0.11 | 12322.36% | $11 → $14 | Maintains | Outperform | Get Alert | |
| 09/12/2024 | FULC | Buy Now | Fulcrum Therapeutics | $12.61 | -68.29% | → $4 | Downgrade | Outperform → Market Perform | Get Alert | |
| 07/03/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | — | — | Upgrade | Market Perform → Outperform | Get Alert | |
| 06/24/2024 | SLDB | Buy Now | Solid Biosciences | $5.71 | 110.16% | $12 → $12 | Upgrade | Market Perform → Outperform | Get Alert | |
| 06/20/2024 | MREO | Buy Now | Mereo BioPharma Group | $2.21 | 261.99% | $6 → $8 | Maintains | Outperform | Get Alert | |
| 03/18/2024 | RGLS | Buy Now | Regulus Therapeutics | — | — | → $6 | Initiates | → Outperform | Get Alert | |
| 03/14/2024 | SPRB | Buy Now | Spruce Biosciences | $83.41 | -97.6% | $9 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/22/2024 | APLT | Buy Now | Applied Therapeutics | $0.11 | 10547.74% | → $12 | Initiates | → Outperform | Get Alert | |
| 02/13/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 536.36% | $23 → $7 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/09/2024 | SYBX | Buy Now | Synlogic | $1.14 | -12.28% | → $1 | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/15/2023 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | → $1 | Downgrade | Outperform → Market Perform | Get Alert | |
| 09/08/2023 | SPRB | Buy Now | Spruce Biosciences | $83.41 | -89.21% | $3 → $9 | Upgrade | Market Perform → Outperform | Get Alert | |
| 08/18/2023 | SELB | Buy Now | Selecta Biosciences | — | — | → $1 | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/15/2023 | DSGN | Buy Now | Design Therapeutics | $9.12 | -34.21% | → $6 | Downgrade | Outperform → Market Perform | Get Alert | |
| 06/13/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $44 → $40 | Downgrade | Outperform → Market Perform | Get Alert | |
| 06/12/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $80 → $115 | Upgrade | Market Perform → Outperform | Get Alert | |
| 03/17/2023 | PTCT | Buy Now | PTC Therapeutics | $76.65 | -37.38% | → $48 | Initiates | → Market Perform | Get Alert | |
| 02/03/2023 | PHVS | Buy Now | Pharvaris | $24.37 | -26.14% | $20 → $18 | Maintains | Outperform | Get Alert | |
| 02/03/2023 | KALV | Buy Now | KalVista Pharma | $16.90 | 18.34% | $30 → $20 | Maintains | Outperform | Get Alert | |
| 02/03/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -57.37% | $33 → $34 | Maintains | Market Perform | Get Alert | |
| 02/03/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 148.9% | $122 → $130 | Maintains | Outperform | Get Alert | |
| 01/20/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 643.63% | → $160 | Reiterates | → Outperform | Get Alert | |
| 01/17/2023 | ASND | Buy Now | Ascendis Pharma | $213.24 | -23.56% | $148 → $163 | Maintains | Outperform | Get Alert | |
| 12/27/2022 | AMTI | Buy Now | Applied Molecular | — | — | $15 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/09/2022 | DSGN | Buy Now | Design Therapeutics | $9.12 | 141.23% | $30 → $22 | Maintains | Outperform | Get Alert | |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $3.88 | 157.73% | $15 → $10 | Maintains | Outperform | Get Alert | |
| 11/14/2022 | ASND | Buy Now | Ascendis Pharma | $213.24 | -30.59% | $168 → $148 | Maintains | Outperform | Get Alert | |
| 11/14/2022 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 2172.73% | $27 → $25 | Maintains | Outperform | Get Alert | |
| 11/10/2022 | SLDB | Buy Now | Solid Biosciences | $5.71 | 5.08% | $1 → $6 | Maintains | Market Perform | Get Alert | |
| 11/10/2022 | PEPG | Buy Now | PepGen | $5.48 | 502.19% | $40 → $33 | Maintains | Outperform | Get Alert | |
| 11/10/2022 | MREO | Buy Now | Mereo BioPharma Group | $2.21 | 81% | $8 → $4 | Maintains | Outperform | Get Alert | |
| 11/08/2022 | AMTI | Buy Now | Applied Molecular | — | — | $21 → $15 | Maintains | Outperform | Get Alert | |
| 11/04/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.53 | -22.73% | $17 → $12 | Maintains | Outperform | Get Alert | |
| 11/03/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.83 | 193.24% | $115 → $108 | Maintains | Outperform | Get Alert | |
| 10/27/2022 | INSM | Buy Now | Insmed | $196.92 | -74.61% | $52 → $50 | Maintains | Outperform | Get Alert | |
| 10/20/2022 | TVTX | Buy Now | Travere Therapeutics | $35.00 | 8.57% | $45 → $38 | Maintains | Outperform | Get Alert | |
| 10/17/2022 | SLDB | Buy Now | Solid Biosciences | $5.71 | -82.49% | $12 → $1 | Downgrade | Outperform → Market Perform | Get Alert | |
| 10/17/2022 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 573.91% | $126 → $145 | Maintains | Outperform | Get Alert | |
| 10/05/2022 | KALV | Buy Now | KalVista Pharma | $16.90 | 77.51% | $45 → $30 | Maintains | Outperform | Get Alert | |
| 09/14/2022 | PHVS | Buy Now | Pharvaris | $24.37 | -17.93% | $25 → $20 | Maintains | Outperform | Get Alert | |
| 08/23/2022 | PHVS | Buy Now | Pharvaris | $24.37 | 2.59% | $45 → $25 | Maintains | Outperform | Get Alert | |
| 08/11/2022 | ASND | Buy Now | Ascendis Pharma | $213.24 | -21.22% | $174 → $168 | Maintains | Outperform | Get Alert | |
| 08/05/2022 | TVTX | Buy Now | Travere Therapeutics | $35.00 | 28.57% | $42 → $45 | Maintains | Outperform | Get Alert | |
| 08/05/2022 | CCXI | Buy Now | ChemoCentryx | — | — | $64 → $52 | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/04/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 133.58% | $115 → $122 | Maintains | Outperform | Get Alert | |
| 07/08/2022 | KALV | Buy Now | KalVista Pharma | $16.90 | 166.27% | $51 → $45 | Maintains | Outperform | Get Alert | |
| 06/06/2022 | SELB | Buy Now | Selecta Biosciences | — | — | → $7 | Initiates | → Outperform | Get Alert | |
| 05/31/2022 | PEPG | Buy Now | PepGen | $5.48 | 629.93% | → $40 | Initiates | → Outperform | Get Alert | |
| 05/26/2022 | CRNX | Buy Now | Crinetics Pharmaceuticals | $49.32 | -20.92% | $36 → $39 | Maintains | Outperform | Get Alert | |
| 05/23/2022 | KDNY | Buy Now | Chinook Therapeutics | — | — | $38 → $44 | Maintains | Outperform | Get Alert | |
| 05/20/2022 | AMTI | Buy Now | Applied Molecular | — | — | $60 → $21 | Maintains | Outperform | Get Alert | |
| 05/12/2022 | IFRX | Buy Now | InflaRx | $0.98 | 308.12% | $6 → $4 | Maintains | Outperform | Get Alert | |
| 05/12/2022 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 25.47% | $34 → $30 | Maintains | Outperform | Get Alert | |
| 05/12/2022 | ASND | Buy Now | Ascendis Pharma | $213.24 | -18.4% | $193 → $174 | Maintains | Outperform | Get Alert | |
| 05/11/2022 | GOSS | Buy Now | Gossamer Bio | $3.88 | 286.6% | $16 → $15 | Maintains | Outperform | Get Alert | |
| 05/11/2022 | RNA | Buy Now | Avidity Biosciences | $71.86 | -30.42% | $53 → $50 | Maintains | Outperform | Get Alert | |
| 05/10/2022 | DSGN | Buy Now | Design Therapeutics | $9.12 | 228.95% | $36 → $30 | Maintains | Outperform | Get Alert | |
| 05/10/2022 | AMTI | Buy Now | Applied Molecular | — | — | $74 → $60 | Maintains | Outperform | Get Alert | |
| 05/06/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.83 | 212.25% | $178 → $115 | Maintains | Outperform | Get Alert | |
| 05/05/2022 | PTGX | Buy Now | Protagonist Therapeutics | $94.79 | -68.35% | $50 → $30 | Maintains | Outperform | Get Alert | |
| 05/03/2022 | QURE | Buy Now | uniQure | $22.63 | 147.46% | $71 → $56 | Maintains | Outperform | Get Alert | |
| 04/28/2022 | SLDB | Buy Now | Solid Biosciences | $5.71 | 162.7% | $12 → $15 | Maintains | Outperform | Get Alert | |
| 04/06/2022 | IMRA | Buy Now | Imara | — | — | $31 → $1 | Downgrade | Outperform → Market Perform | Get Alert | |
| 03/30/2022 | PHVS | Buy Now | Pharvaris | $24.37 | 84.65% | $50 → $45 | Maintains | Outperform | Get Alert | |
| 03/25/2022 | IFRX | Buy Now | InflaRx | $0.98 | 512.18% | $8 → $6 | Maintains | Outperform | Get Alert | |
| 03/24/2022 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | $25 → $15 | Maintains | Outperform | Get Alert | |
| 03/18/2022 | SYBX | Buy Now | Synlogic | $1.14 | 601.75% | $11 → $8 | Maintains | Outperform | Get Alert | |
| 03/16/2022 | SPRB | Buy Now | Spruce Biosciences | $83.41 | -96.4% | $5 → $3 | Maintains | Market Perform | Get Alert | |
| 03/16/2022 | IMRA | Buy Now | Imara | — | — | $37 → $31 | Maintains | Outperform | Get Alert | |
| 03/15/2022 | ASND | Buy Now | Ascendis Pharma | $213.24 | -9.49% | $190 → $193 | Maintains | Outperform | Get Alert | |
| 03/08/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.53 | 41.66% | $30 → $22 | Maintains | Outperform | Get Alert | |
| 02/24/2022 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 28.58% | $16 → $14 | Maintains | Outperform | Get Alert | |
| 02/22/2022 | INSM | Buy Now | Insmed | $196.92 | -73.59% | $57 → $52 | Maintains | Outperform | Get Alert | |
| 01/14/2022 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 46.95% | $12 → $16 | Upgrade | Market Perform → Outperform | Get Alert | |
| 12/16/2021 | TVTX | Buy Now | Travere Therapeutics | $35.00 | 20% | $37 → $42 | Maintains | Outperform | Get Alert | |
| 12/14/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $112 → $100 | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/10/2021 | RNA | Buy Now | Avidity Biosciences | $71.86 | -26.25% | $36 → $53 | Maintains | Outperform | Get Alert | |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $282 → $35 | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/22/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 120.18% | $112 → $115 | Maintains | Outperform | Get Alert | |
| 11/16/2021 | SPRB | Buy Now | Spruce Biosciences | $83.41 | -94.01% | $35 → $5 | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/15/2021 | ASND | Buy Now | Ascendis Pharma | $213.24 | -10.9% | $182 → $190 | Maintains | Outperform | Get Alert | |
| 11/15/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 114.44% | $108 → $112 | Maintains | Outperform | Get Alert | |
| 11/11/2021 | SYBX | Buy Now | Synlogic | $1.14 | 864.91% | $15 → $11 | Maintains | Outperform | Get Alert | |
| 11/09/2021 | GOSS | Buy Now | Gossamer Bio | $3.88 | 312.37% | $15 → $16 | Maintains | Outperform | Get Alert | |
| 11/04/2021 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.53 | 125.37% | $28 → $35 | Maintains | Outperform | Get Alert | |
| 10/12/2021 | PTGX | Buy Now | Protagonist Therapeutics | $94.79 | -47.25% | $35 → $50 | Maintains | Outperform | Get Alert | |
| 10/11/2021 | CCXI | Buy Now | ChemoCentryx | — | — | $17 → $64 | Upgrade | Market Perform → Outperform | Get Alert | |
| 09/30/2021 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 10.21% | $13 → $12 | Maintains | Market Perform | Get Alert | |
| 09/20/2021 | PTGX | Buy Now | Protagonist Therapeutics | $94.79 | -63.08% | $50 → $35 | Maintains | Outperform | Get Alert | |
| 08/26/2021 | ASND | Buy Now | Ascendis Pharma | $213.24 | -14.65% | $178 → $182 | Maintains | Outperform | Get Alert | |
| 08/17/2021 | TVTX | Buy Now | Travere Therapeutics | $35.00 | 5.71% | $27 → $37 | Maintains | Outperform | Get Alert | |
| 08/13/2021 | FULC | Buy Now | Fulcrum Therapeutics | $12.61 | 193.36% | $23 → $37 | Maintains | Outperform | Get Alert | |
| 08/10/2021 | GOSS | Buy Now | Gossamer Bio | $3.88 | 286.6% | $19 → $15 | Maintains | Outperform | Get Alert | |
| 08/05/2021 | PTGX | Buy Now | Protagonist Therapeutics | $94.79 | -47.25% | $41 → $50 | Maintains | Outperform | Get Alert | |
| 07/21/2021 | ASND | Buy Now | Ascendis Pharma | $213.24 | -16.53% | $181 → $178 | Maintains | Outperform | Get Alert | |
| 06/14/2021 | ASND | Buy Now | Ascendis Pharma | $213.24 | -15.12% | $191 → $181 | Maintains | Outperform | Get Alert | |
| 05/07/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $90 → $112 | Maintains | Outperform | Get Alert | |
| 05/07/2021 | CCXI | Buy Now | ChemoCentryx | — | — | $84 → $17 | Downgrade | Outperform → Market Perform | Get Alert | |
| 05/04/2021 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | → $25 | Initiates | → Outperform | Get Alert | |
| 04/20/2021 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 42.2% | → $34 | Initiates | → Outperform | Get Alert | |
| 04/20/2021 | DSGN | Buy Now | Design Therapeutics | $9.12 | 294.74% | → $36 | Initiates | → Outperform | Get Alert | |
| 03/22/2021 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 19.39% | $15 → $13 | Maintains | Market Perform | Get Alert | |
| 03/16/2021 | SLDB | Buy Now | Solid Biosciences | $5.71 | 162.7% | $3 → $15 | Upgrade | Market Perform → Outperform | Get Alert | |
| 03/08/2021 | IMRA | Buy Now | Imara | — | — | $59 → $42 | Maintains | Outperform | Get Alert | |
| 03/03/2021 | PTGX | Buy Now | Protagonist Therapeutics | $94.79 | -56.75% | $30 → $41 | Maintains | Outperform | Get Alert | |
| 03/02/2021 | PHVS | Buy Now | Pharvaris | $24.37 | 105.17% | → $50 | Initiates | → Outperform | Get Alert | |
| 03/02/2021 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 485.61% | $125 → $126 | Maintains | Outperform | Get Alert | |
| 02/24/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $92 → $90 | Maintains | Outperform | Get Alert | |
| 02/22/2021 | AMTI | Buy Now | Applied Molecular | — | — | $32 → $74 | Maintains | Outperform | Get Alert | |
| 02/16/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.83 | 383.3% | $115 → $178 | Maintains | Outperform | Get Alert | |
| 02/12/2021 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 37.76% | $30 → $15 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/10/2021 | KALV | Buy Now | KalVista Pharma | $16.90 | 201.78% | $39 → $51 | Maintains | Outperform | Get Alert | |
| 01/27/2021 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.53 | 80.3% | $24 → $28 | Maintains | Outperform | Get Alert | |
| 01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 480.96% | $197 → $125 | Maintains | Outperform | Get Alert | |
| 01/04/2021 | INSM | Buy Now | Insmed | $196.92 | -72.07% | $51 → $55 | Maintains | Outperform | Get Alert | |
| 12/14/2020 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 175.52% | $24 → $30 | Maintains | Outperform | Get Alert | |
| 11/17/2020 | KALV | Buy Now | KalVista Pharma | $16.90 | 130.77% | $28 → $39 | Maintains | Outperform | Get Alert | |
| 11/12/2020 | ASND | Buy Now | Ascendis Pharma | $213.24 | -10.43% | $173 → $191 | Maintains | Outperform | Get Alert | |
| 11/10/2020 | FULC | Buy Now | Fulcrum Therapeutics | $12.61 | 82.36% | $25 → $23 | Maintains | Outperform | Get Alert | |
| 11/10/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $91 → $92 | Maintains | Outperform | Get Alert | |
| 11/06/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 106.78% | $113 → $108 | Reiterates | → Outperform | Get Alert | |
| 11/06/2020 | IFRX | Buy Now | InflaRx | $0.98 | 920.3% | $7 → $10 | Upgrade | Market Perform → Outperform | Get Alert | |
| 11/06/2020 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 120.42% | $19 → $24 | Maintains | Outperform | Get Alert | |
| 11/06/2020 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 815.59% | $214 → $197 | Maintains | Outperform | Get Alert | |
| 11/03/2020 | SPRB | Buy Now | Spruce Biosciences | $83.41 | -58.04% | → $35 | Initiates | → Outperform | Get Alert | |
| 10/29/2020 | CCXI | Buy Now | ChemoCentryx | — | — | $75 → $84 | Maintains | Outperform | Get Alert | |
| 10/28/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.83 | 212.25% | $110 → $115 | Maintains | Outperform | Get Alert | |
| 10/13/2020 | GOSS | Buy Now | Gossamer Bio | $3.88 | 647.42% | $36 → $29 | Maintains | Outperform | Get Alert | |
| 10/07/2020 | KDNY | Buy Now | Chinook Therapeutics | — | — | → $38 | Initiates | → Outperform | Get Alert | |
| 08/19/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 116.35% | $140 → $113 | Maintains | Outperform | Get Alert | |
| 08/06/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $73 → $91 | Maintains | Outperform | Get Alert | |
| 08/05/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 168.05% | $130 → $140 | Maintains | Outperform | Get Alert | |
| 07/07/2020 | RNA | Buy Now | Avidity Biosciences | $71.86 | -49.9% | → $36 | Initiates | → Outperform | Get Alert | |
| 06/30/2020 | AMTI | Buy Now | Applied Molecular | — | — | → $32 | Initiates | → Outperform | Get Alert | |
| 06/12/2020 | IMRA | Buy Now | Imara | — | — | $27 → $64 | Maintains | Outperform | Get Alert | |
| 05/22/2020 | PTGX | Buy Now | Protagonist Therapeutics | $94.79 | -68.35% | $17 → $30 | Maintains | Outperform | Get Alert | |
| 05/20/2020 | ASND | Buy Now | Ascendis Pharma | $213.24 | -18.87% | $170 → $173 | Maintains | Outperform | Get Alert | |
| 05/20/2020 | GOSS | Buy Now | Gossamer Bio | $3.88 | 827.84% | $27 → $36 | Reiterates | → Outperform | Get Alert | |
| 05/12/2020 | CCXI | Buy Now | ChemoCentryx | — | — | $54 → $65 | Reiterates | → Outperform | Get Alert | |
| 05/08/2020 | IMRA | Buy Now | Imara | — | — | $25 → $27 | Reiterates | → Outperform | Get Alert | |
| 05/07/2020 | IFRX | Buy Now | InflaRx | $0.98 | 614.21% | $4 → $7 | Maintains | Market Perform | Get Alert | |
| 04/20/2020 | ASND | Buy Now | Ascendis Pharma | $213.24 | -20.28% | $152 → $170 | Maintains | Outperform | Get Alert | |
| 04/06/2020 | IMRA | Buy Now | Imara | — | — | → $25 | Initiates | → Outperform | Get Alert | |
| 08/19/2019 | SLDB | Buy Now | Solid Biosciences | $5.71 | — | — | Upgrade | Market Perform → Outperform | Get Alert | |
| 03/05/2019 | GOSS | Buy Now | Gossamer Bio | $3.88 | — | — | Initiates | → Outperform | Get Alert | |
| 01/24/2019 | ASND | Buy Now | Ascendis Pharma | $213.24 | -57.79% | $73 → $90 | Upgrade | Market Perform → Outperform | Get Alert | |
| 07/19/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.83 | 157.94% | $68 → $95 | Maintains | Outperform | Get Alert | |
| 06/20/2018 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 810.94% | $121 → $196 | Maintains | Outperform | Get Alert | |
| 03/13/2018 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 327.58% | $79 → $92 | Maintains | Outperform | Get Alert | |
| 02/23/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 152.73% | $142 → $132 | Maintains | Outperform | Get Alert | |
| 02/08/2018 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 120.42% | $20 → $24 | Maintains | Outperform | Get Alert | |
| 01/05/2018 | RGLS | Buy Now | Regulus Therapeutics | — | — | → $2 | Initiates | → Outperform | Get Alert | |
| 12/12/2017 | ONCE | Buy Now | Spark Therapeutics | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 10/23/2017 | NITE | Buy Now | Nightstar Therapeutics plc - American Depositary Shares | $37.13 | -32.67% | → $25 | Initiates | → Outperform | Get Alert | |
| 10/23/2017 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.53 | -9.85% | $10 → $14 | Maintains | Outperform | Get Alert | |
| 10/19/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 171.87% | $136 → $142 | Maintains | Outperform | Get Alert | |
| 09/26/2017 | PRQR | Buy Now | ProQR Therapeutics | $2.40 | 400% | $10 → $12 | Maintains | Outperform | Get Alert | |
| 09/19/2017 | SYBX | Buy Now | Synlogic | $1.14 | 2092.98% | → $25 | Initiates | → Outperform | Get Alert | |
| 09/13/2017 | RETA | Buy Now | Reata Pharmaceuticals | — | — | → $43 | Initiates | → Outperform | Get Alert | |
| 08/28/2017 | CMTA | Buy Now | Clementia Pharmaceuticals Inc. - Common Shares | — | — | → $23 | Initiates | → Outperform | Get Alert | |
| 05/19/2017 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | → $5 | Initiates | → Outperform | Get Alert | |
| 05/18/2017 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | — | Upgrade | Market Perform → Outperform | Get Alert | |
| 03/09/2017 | ASND | Buy Now | Ascendis Pharma | $213.24 | -85.93% | $24 → $30 | Downgrade | Outperform → Market Perform | Get Alert | |
| 03/02/2017 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 118.44% | $27 → $47 | Upgrade | Market Perform → Outperform | Get Alert | |
| 02/09/2017 | ONCE | Buy Now | Spark Therapeutics | — | — | → $85 | Initiates | → Outperform | Get Alert | |
| 05/04/2016 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | $7 → $9 | Maintains | Market Perform | Get Alert | |
| 05/02/2016 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | -76.76% | $13 → $5 | Downgrade | Market Perform → Underperform | Get Alert | |
| 02/23/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 129.75% | $149 → $120 | Maintains | Outperform | Get Alert | |
| 02/19/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.83 | 117.21% | → $80 | Initiates | → Outperform | Get Alert | |
| 01/29/2016 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/06/2015 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 25.49% | $33 → $27 | Maintains | Market Perform | Get Alert | |
| 10/05/2015 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 92.87% | $23 → $21 | Maintains | Outperform | Get Alert | |
| 03/04/2015 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | 19.39% | $9 → $13 | Maintains | Outperform | Get Alert | |
| 02/23/2015 | ASND | Buy Now | Ascendis Pharma | $213.24 | -85.93% | → $30 | Initiates | → Outperform | Get Alert | |
| 02/02/2015 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.53 | -48.49% | → $8 | Initiates | → Outperform | Get Alert | |
| 10/13/2014 | PRQR | Buy Now | ProQR Therapeutics | $2.40 | 900% | → $24 | Initiates | → Outperform | Get Alert | |
| 07/01/2014 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | -44.9% | $2.5 → $6 | Upgrade | Market Perform → Outperform | Get Alert | |
| 11/12/2013 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | -20.99% | $44 → $17 | Maintains | Market Perform | Get Alert | |
| 10/24/2013 | FOLD | Buy Now | Amicus Therapeutics | $10.89 | — | — | Downgrade | → Market Perform | Get Alert | |
| 04/16/2013 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 03/05/2013 | SRPT | Buy Now | Sarepta Therapeutics | $21.52 | 109.14% | → $45 | Initiates | → Outperform | Get Alert | |
| 02/06/2013 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | — | Assumes | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved